Cisplatin Ototoxicity: Examination of the Impact of Dosing, Infusion Times, and Schedules In Pediatric Cancer Patients

BACKGROUND: Sensorineural hearing loss is a well-known side effect of cisplatin (CDDP). There is limited research on the effect of dosing, infusion times, and schedules of cisplatin administration and their impact on hearing loss. METHODS: A retrospective review of 993 pediatric patients’ medical an...

Descripción completa

Detalles Bibliográficos
Autores principales: Camet, Miranda L., Spence, Anne, Hayashi, Susan S., Wu, Ningying, Henry, Jennifer, Sauerburger, Kara, Hayashi, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274419/
https://www.ncbi.nlm.nih.gov/pubmed/34262862
http://dx.doi.org/10.3389/fonc.2021.673080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8274419/
https://www.ncbi.nlm.nih.gov/pubmed/34262862
http://dx.doi.org/10.3389/fonc.2021.673080

Ejemplares similares